Literature DB >> 8871595

Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells.

F J Kos1, E G Engleman.   

Abstract

Recently we reported that natural killer (NK) cells are critical accessory cells required for the differentiation of alloantigen-stimulated CD8+ T cells into effector cytotoxic T lymphocytes (CTL) in vitro. In this study we provide evidence that NK cells are also required for the generation of influenza virus-specific CTL. Depletion of NK cells from responder human peripheral blood mononuclear cells or mouse splenocytes abolished the induction of influenza A virus-specific CTL under culture conditions. Treatment of C57BL/6 mice with the NK cell-depleting NK1.1 monoclonal antibody (mAb) before primary or secondary immunization with influenza A virus abrogated the capacity of CTL precursors to differentiate into influenza virus-specific CTL effectors in vivo. These results extend our previous findings and demonstrate that NK cells critically influence the induction of antigen-specific CTL, both in vitro and in vivo.

Entities:  

Mesh:

Year:  1996        PMID: 8871595     DOI: 10.1006/cimm.1996.0245

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  30 in total

Review 1.  Evasion of natural killer cells by influenza virus.

Authors:  Hailong Guo; Pawan Kumar; Subramaniam Malarkannan
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

2.  Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice.

Authors:  P G Stevenson; G T Belz; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 3.  Regulation of adaptive immunity by natural killer cells.

Authors:  F J Kos
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

4.  Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection.

Authors:  Yuan Liu; Jian Zheng; Yinping Liu; Liyan Wen; Lei Huang; Zheng Xiang; Kwok-Tai Lam; Aizhen Lv; Huawei Mao; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2017-04-17       Impact factor: 11.530

5.  T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.

Authors:  Xiao-Song He; Monia Draghi; Kutubuddin Mahmood; Tyson H Holmes; George W Kemble; Cornelia L Dekker; Ann M Arvin; Peter Parham; Harry B Greenberg
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 6.  Tissue-specific effector functions of innate lymphoid cells.

Authors:  Niklas K Björkström; Eliisa Kekäläinen; Jenny Mjösberg
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

Review 7.  Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity.

Authors:  A Fuchs; M Colonna
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23

8.  Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma.

Authors:  Vanaja Konduri; Dali Li; Matthew M Halpert; Dan Liang; Zhengdong Liang; Yunyu Chen; William E Fisher; Silke Paust; Jonathan M Levitt; Qizhi Cathy Yao; William K Decker
Journal:  Oncoimmunology       Date:  2016-07-22       Impact factor: 8.110

9.  Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses.

Authors:  Lisa M Kronstad; Christof Seiler; Rosemary Vergara; Susan P Holmes; Catherine A Blish
Journal:  J Immunol       Date:  2018-08-24       Impact factor: 5.422

10.  Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection.

Authors:  Corine H GeurtsvanKessel; Ingrid M Bergen; Femke Muskens; Louis Boon; Henk C Hoogsteden; Albert D M E Osterhaus; Guus F Rimmelzwaan; Bart N Lambrecht
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.